European shares tick higher after Friday selloff; Swiss stocks slumpEuropean shares edged higher on Monday, recovering some ground after a sharp selloff on Friday, while Swiss stocks slumped to their lowest ...
New Zealand government is leaking info and finding a culprit in mediaThe New Zealand government continues to struggle with unauthorized leaks from public servants, prompting investigations and internal warnin...
Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobsSwiss pharmaceutical giant Roche announced a $50 billion U.S. investment to expand R&D and manufacturing, countering Trump-era tariffs and ...
Roche India arm leases 2 lakh sq ft office spaceRoche Information Solutions India, the healthcare digital entity of the global pharmaceutical major, will be paying rentals of over ₹210 cr...
Why pharma may not fear the latest drug-price probeAs uncomfortable as it will be for the drugmakers, it may not result in much lasting damage.
Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...
- Galatasaray parts ways with head coach Riekerink - CNN Turk
SOCCER-TURKEY-GALATASARAY:Galatasaray parts ways with head coach Riekerink - CNN Turk
- Soccer-Galatasaray parts ways with head coach Riekerink - CNN Turk
SOCCER-TURKEY/GALATASARAY:Soccer-Galatasaray parts ways with head coach Riekerink - CNN Turk
- Soccer-Barcelona searching for consistency in La Liga
SOCCER-SPAIN-FCB/ENRIQUE:Soccer-Barcelona searching for consistency in La Liga
European shares slip as energy and bank stocks fallThe STOXX Europe 600 Oil & Gas index fell 0.5%, making it the top sectoral faller, after crude oil prices slipped back below the $50-per-ba...
Roche begins probe into Avastin use for eye ailmentsRoche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...
Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
- Hotel industry on recovery path, room tariff goes up: Report
The hotel tariff went up by 12% in the first 6 months of this yr in the country amid rise in demand for hotel rooms from domestic traveller...
- Ranbaxy settles patent dispute with Roche
Daiichi Sankyo-owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for the latter’s drug valganciclovir sold u...
- Hetero bags UAE deal for swine flu drug
The United Arab Emirates’ health ministry has given approval to Neopharma to manufacture a version of flu drug Tamiflu in a joint venture w...
- Natco plans copy of Roche cancer drug
Some more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...
- Roche files for Avastin to treat breast cancer in Europe
Swiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...